A Study of Safety and Efficacy Comparing ABT-874 Versus Methotrexate in Subjects With Moderate to Severe Plaque Psoriasis

NCT00679731 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

317

Enrollment

INDUSTRY

Sponsor class

Conditions

Psoriasis

Interventions

DRUG: ABT-874
DRUG: Methotrexate

Sponsor

AbbVie (prior sponsor, Abbott)